Skip to main content

Technology

REAC® Technology: what it is and how it works.

A non-invasive technology, applied with medical devices according to standardized protocols.

What is REAC® Technology

REAC® – Radio Electric Asymmetric Conveyer – is a neuromodulation and biomodulation technology designed to interact with the body’s endogenous bioelectric activity. It uses radioelectric signals of very low intensity, conveyed through a proprietary asymmetric system, to modulate specific functional nervous and biological processes. Applied through dedicated medical devices and standardized protocols, it offers the professional a non-invasive, reproducible approach that can be easily integrated into clinical practice.

Treatment is painless and without the administration of drugs: it takes place by contact or proximity, with limited application times and defined and repeatable sequences. The application is aimed at the body’s adaptation processes, with the aim of supporting its physiological capacity to respond to trauma and chronic stress.

  • Non-invasive, painless, without medication
  • Standardized, defined and repeatable protocols
  • Studies published and indexed on PubMed
Medical device BENE Mod 110 based on REAC technology in clinical environment

How it works

The principle of operation

Animated Conceptual Illustration: from the device BENE Mod 110 radio waves propagate to a network of connected points that illuminate sequentially.
01

Radioelectric emission

The device generates very low-intensity radioelectric fields, according to the parameters defined in the technical documentation.

02

Asymmetric conveyance

The ACP probe — Asymmetric Conveyer Probe — conveys the radioelectric fields asymmetrically to the point of application.

03

Application for protocols

The treatment follows standardized neuromodulation and biomodulation protocols, with defined sequences and times.

Instructions for use, indications, contraindications and warnings are given in the technical documentation and in the instructions for use of the device.

A technology documented by research.

REAC® Technology studies are published in scientific journals and indexed in PubMed. The publications cover the areas of application of neuromodulation and biomodulation protocols.

  • Indexed scientific publications on PubMed
  • Continuous research and development since 2002
  • Devices with CE marking and ISO 13485:2016 quality system

Do you want to evaluate REAC® Technology for your clinical practice?

Talk to us: We present you devices, protocols and integration path.

Contact us